Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03236831
Other study ID # 17-001893
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 11, 2017
Est. completion date February 17, 2019

Study information

Verified date October 2019
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators are doing this research to find out if more careful assessment and elimination of potential risk factors of acute kidney injury (AKI) during the subject's perioperative period will reduce their chance of kidney damage and kidney damage related problems.


Description:

The purpose of the study is to investigate whether preventive measures for patients undergoing ventricular assist device (VAD) placement will reduce AKI occurrence, progression and associated complications.

Participants will be in the study for a total of 6 days (1 day prior to the surgery and 5 days after the surgery). The investigators will review the participant's medical record up to one year after surgery.

The study investigators will access the participant's electronic medical record 24 hours prior to the planned VAD implantation and review the participant's medication regimen and provide recommendations to the participant's primary care physician in an effort to minimize potential risks for AKI. There will be no intervention during the operation.

The clinical recommendations will cover the following:

1. Avoidance of potentially nephrotoxic agents.

2. Optimizing volume status (avoidance of volume overload or depletion)

3. Optimizing electrolytes and acid-base status

4. Minimizing IV contrast exposure when appropriate

5. Treating severe anemia

6. Optimization of hemodynamics (Mean arterial BP>65mmHg).

The investigators plan to compare the results of this study with the historical data in the same patient population in the years of 7/1/2015-6/30/2017.


Recruitment information / eligibility

Status Completed
Enrollment 210
Est. completion date February 17, 2019
Est. primary completion date February 17, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria:

- Adult patients that will undergo VAD placement.

- Patients able to give consent

Exclusion criteria:

- Patients on dialysis (hemodialysis or peritoneal dialysis)

- Non-elective VAD placement (VAD implantation decision made within 24 hours)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Clinical Recommendations
The investigators will provide clinical recommendations to the subject's primary care provider. These will be in regards to the following: Avoidance of potentially nephrotoxic medications. Optimizing volume status (avoidance of volume overload or depletion) Optimizing electrolytes and acid-base status Minimizing IV contrast exposure when appropriate Treating severe anemia Optimization of hemodynamics (Mean arterial BP>65mmHg)

Locations

Country Name City State
United States Mayo Clinic in Rochester Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of postoperative AKI (within 5 post-op days) based on AKIN criteria The Acute Kidney Injury Network (AKIN) staging system has 3 stages: 1) serum creatinine increase = 26.5 umol/L or increase to 1.5-2.0 fold from baseline, OR urine output <0.5 ml/kg/h for 6 h; 2) serum creatinine increase > 2.0-3.0 fold from baseline OR urine output <0.5 ml/kg/h for 12 h; 3) serum creatinine increase >3.0 fold from baseline OR serum creatinine =354 umol/l with an acute increase of at least 44 umol/l or need for Renal Replacement Therapy (RRT) OR urine output <0.3 ml/kg/h for 24 h OR anuria for 12 OR need for RRT 5 days after the surgery
Secondary Severity of postoperative AKI (within 5 post-op days) based on AKIN criteria The AKIN staging system has 3 stages: 1) serum creatinine increase = 26.5 umol/L or increase to 1.5-2.0 fold from baseline, OR urine output <0.5 ml/kg/h for 6 h; 2) serum creatinine increase > 2.0-3.0 fold from baseline OR urine output <0.5 ml/kg/h for 12 h; 3) serum creatinine increase >3.0 fold from baseline OR serum creatinine =354 umol/l with an acute increase of at least 44 umol/l or need for Renal Replacement Therapy (RRT) OR urine output <0.3 ml/kg/h for 24 h OR anuria for 12 OR need for RRT 5 days after the surgery
Secondary Length of hospital stay The length of hospital stay will be determined from the electronic medical record. 1 year after the surgery
Secondary In hospital (perioperative) mortality and one-year mortality The number of subjects who died in hospital (perioperatively) and one year after surgery Approximately 5 days after surgery, one year after enrollment
See also
  Status Clinical Trial Phase
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Terminated NCT04051957 - Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury Phase 2
Completed NCT04985292 - Does Probiotic Supplementation Prevent Kidney Injury During Strenuous Physical Exercise? N/A
Completed NCT04933604 - LPN in Patients With High-complex Renal Tumors
Recruiting NCT05229328 - Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
Completed NCT02242006 - Antimicrobial Pharmacokinetics in Critically Ill Adults During Sustained Low Efficiency Dialysis (SLED)
Terminated NCT05747053 - Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
Completed NCT03407573 - Restrictive vs Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur N/A
Withdrawn NCT00793013 - Airway Pressure Release Ventilation (APRV) Compared to ARDSnet Ventilation Phase 2
Not yet recruiting NCT06108765 - Acute Kidney Injury in Poly Trauma Patients
Recruiting NCT05155358 - Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Stroke
Completed NCT06008223 - Clinical Analysis of Vitamin B6 in Sepsis N/A
Completed NCT04869462 - DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)
Recruiting NCT04626323 - Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease Phase 2
Active, not recruiting NCT02037321 - Meta-Analyses of the Effect of Vegetable Protein for Animal Protein on Cardiometabolic Risk N/A
Completed NCT00819871 - Nuclear Factor Kappa-B (NFKB1) Polymorphism and Organ Injury After Cardiac Surgery N/A
Recruiting NCT05812755 - SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery Phase 4
Recruiting NCT04902846 - Immune Checkpoint Inhibitors Nephrotoxicity
Recruiting NCT04752293 - Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Completed NCT03139123 - Prevalence of Hypotension Associated With Preload Dependence During Continuous Renal Replacement Therapy

External Links